Spotted Fever Treatment Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2024-2036. The growth of the market can be primarily attributed to the increasing prevalence of bacterial infections, coupled with improper maintenance of hygiene in homes and nearby surroundings. According to the Centers for Disease Control and Prevention (CDC), as of 2019, antibiotic resistant fungi and bacteria cause more than 2.8 million infections and 35,000 deaths in the United States each year. Along with these, growing trend of travel and forest tourism, especially in North and South American countries, is assessed to lead to high exposure of a large number of people to several different species of ticks, which are the only cause of spotted fever. This is in turn is predicted to drive robust growth to the growth in the forthcoming years. Furthermore, rise in healthcare spending is projected to offer abundant opportunities to market players in the near future.
Growth Drivers
Challenges
The market is segmented by treatment into doxycycline, chloramphenicol, and others, out of which, the doxycycline segment is anticipated to hold the largest share in the global spotted fever treatment market. This can be accounted to the fact that using antibiotics other than doxycycline is associated with higher risk of fatal outcome from spotted fever, and its excellent effectiveness in preventing severe complications from the illness. Apart from this, when treated with this drug, fever generally subsides within 24-48 hours, which is expected to augment its sales in the years to come. Additionally, on the basis of end user, the hospitals segment is evaluated to grab the largest share over the forecast period owing to the high preference of patients to be treated under the supervision of a professional in a hospital facility.
Our in-depth analysis of the global spotted fever treatment market includes the following segments
|
By Treatment |
|
|
By End User |
|
|
By Drug Distribution Channel
|
|
On the basis of geographical analysis, the global spotted fever treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. North America industry is poised to account for largest revenue share by 2036, backed by high number of cases of patients with spotted fever, and presence of climatic conditions favoring the occurrence of tickborne diseases. As per another report by the CDC, the total cases of spotted fever in the U.S. have risen in the last 2 decades, from 495 cases in 2000, to 6,248 cases in 2017. However, 5,544 and 5,207 cases of the disease were reported in 2018 and 2019 respectively.
In addition, large healthcare expenditure is also a major factor projected to boost the growth of the market in the coming years. Moreover, the market in Latin America is also anticipated to grab a sizeable share during the forecast period ascribing to the growing prevalence of tick-based infections and improper maintenance of cleanliness in various parts of the region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?